RNAi Reporter Construct for High-Throughput Potency Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying potent RNAi molecules are inefficient, as existing design algorithms fail to accurately predict potency and often include dysfunctional predictions, necessitating experimental validation for each molecule, which is labor-intensive and not suitable for high-throughput approaches.
Innovation Solution
A system combining a sequence encoding an RNAi molecule with a reporter and a target sequence on a single construct allows for high-throughput functional screening of RNAi molecules by measuring reporter expression levels, enabling the identification of potent RNAi molecules and informing RNAi design for therapeutic applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If design algorithms are used to predict RNAi molecule potency, then the number of predicted molecules increases, but the accuracy of potency prediction decreases
Solution Approach 1:
The patent creates a synthetic reporter construct that copies the essential features of the RNAi pathway (dsRNA processing, RISC loading, target mRNA degradation) in a simplified, measurable format. This artificial system allows quantitative assessment of RNAi molecule potency without requiring complex cellular contexts or difficult-to-measure parameters like protein knockdown efficiency.
Solution Approach 2:
The patent replaces complex biological measurement systems (protein analysis, qRT-PCR, Western blots) with a simpler optical measurement system. The reporter construct uses fluorescent or luminescent signals that can be quantified through flow cytometry or plate readers, substituting difficult biochemical measurements with easier optical readouts that directly report on RNAi efficiency.
2Measurement precision
If experimental validation is performed for each predicted RNAi molecule, then the accuracy of potency determination improves, but the time and labor required increases
Solution Approach 1:
The patent designs a universal reporter construct system that can simultaneously evaluate multiple RNAi molecules against different target sequences in parallel. The construct incorporates variable target mRNA sequences and reporter genes that can be adapted to test various RNAi candidates in a single experimental platform, eliminating the need for separate validation assays for each molecule.
Solution Approach 2:
The patent transitions from sequential, one-at-a-time validation to parallel, high-dimensional screening. By incorporating multiple target sequences and reporter variants into a single construct library, the system enables simultaneous evaluation of numerous RNAi molecules across different targets, adding a dimension of parallelism that dramatically reduces validation time and labor.
3Reliability
If traditional validation methods (Western blots, qRT-PCR) are used, then the reliability of knockdown assessment improves, but the throughput decreases
Solution Approach 1:
The patent creates a simplified copy of the RNAi validation process embedded in the reporter construct itself. The construct includes a reporter gene whose expression level directly reports on the effectiveness of RNAi-mediated knockdown, copying the essential measurement function while eliminating the need for separate Western blots or qRT-PCR assays.
Solution Approach 2:
The patent substitutes complex, low-throughput biochemical analysis methods with high-throughput optical detection. The reporter construct generates fluorescent or luminescent signals that can be rapidly quantified using flow cytometry or microplate readers, replacing time-consuming protein electrophoresis or nucleic acid amplification with quick optical measurements that maintain reliable knockdown assessment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables rapid and simultaneous testing of RNAi molecules, identifying the most potent ones and determining target sequences, thereby improving the efficiency of RNAi design and validation, particularly in high-throughput settings, and informing therapeutic applications.
Implementation Method 1
RNAi is a sequence-specific posttranscriptional gene silencing mechanism triggered by double-stranded RNA (dsRNA). It causes degradation or translational repression of mRNAs complementary in sequence to the dsRNA.
Data Source
AI summary
Provided is a single construct combining a sequence encoding an RNAi molecule, a sequence encoding a reporter, and a target sequence specific for the RNAi molecule. The construct can be used to determine the potency of the encoded RNAi molecule in a direct and unbiased way. These results can be used to inform the design of potent RNAi molecules of various types and can be extended to several other applications, including: (1) generation of tiled libraries comprising every possible RNAi molecule-encoding sequence for a given gene target; (2) large-scale parallel validation of RNAi molecules targeting many genes to generate validated RNAi molecule-encoding libraries; (3) experimental comparison of design algorithms and strategies; and (4) investigation of RNAi biology in target site mutagenesis assays by screening pools containing single nucleotide changes in target sites and/or in the RNAi molecule to identify the most relevant sequence characteristics of potent RNAi-target site predictions.